Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: Secondary analysis of the Euro-Ewing99-R1 trial

Berg, H. van den; Paulussen, M.; Teuff, G. le; Judson, I.; Gelderblom, H.; Dirksen, U.; ... ; Euro-EWING99 Grp (2015)

Article / Letter to editor

• Ewing sarcomas
• Alkylating agent
• Gender
• Efficacy
• Toxicity
• Interaction
• Metabolism
• Constitutive androstane receptor
• CYP3A4
• CYP2B6

• All authors: Berg, H. van den; Paulussen, M.; Teuff, G. le; Judson, I.; Gelderblom, H.; Dirksen, U.; Brennan, B.; Whelan, J.; Ladenstein, R.L.; Marec-Berard, P.; Kruseova, J.; Hjorth, L.; Kuhne, T.; Brichard, B.; Wheatley, K.; Craft, A.; Juergens, H.; Gaspar, N.; Deley, M.C. le; Euro-EWING99 Grp
• Date: 2015-11-30
• Journal: European Journal of Cancer
• Volume: 51
• Issue: 16
• Pages: 2453 - 2464
• DOI: doi:10.1016/j.ejca.2015.06.123